Charles Lenz is a Cardiology physician. OpenAlex indexes 37 publications with 1,292 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
222 N 7th St
Bismarck, ND 585014436
Telephone
701-323-5422Provider last certified this registry record 31 Mar 2022.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20255 payments
- Actelion Pharmaceuticals US, Inc.Program year20252 payments
- PFIZER INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77%Beta blocker18.1%Metoprolol Succinate59%Carvedilol23%Metoprolol Tartrate17%Atenolol2%Part D≥314 patientsStatin16.2%Rosuvastatin Calcium58%Atorvastatin Calcium32%Pravastatin Sodium8%Simvastatin2%Part D≥278 patients+ 17 more classes in this area
Blood & clotting
14.6%Factor Xa inhibitor10.8%Eliquis79%Xarelto21%Part D≥159 patientsP2Y12 inhibitor2.5%Clopidogrel85%Brilinta8%Prasugrel Hcl6%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
7.6%SGLT2 inhibitor4.8%Jardiance84%Farxiga16%Part D≥72 patientsPotassium supplement1.7%Potassium Chloride71%Klor-Con M2029%Part D≥34 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sinus rhythm heart rate increase after atrial fibrillation ablation is associated with lower risk of arrhythmia recurrence
Pacing and Clinical Electrophysiology
2021 - Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
Journal of Thrombosis and Haemostasis
2019 - The evolution of treatment and complications of esophageal food impaction
United European Gastroenterology Journal
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”